Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
PHARMACEUTICAL COMPOSITION FOR INHIBITING METASTASIS OF CANCER, COMPRISING, AS ACTIVE INGREDIENT, ANTIBODY THAT SPECIFICALLY BINDS TO EPIDERMAL GROWTH FACTOR RECEPTOR

No-Receipt date 2022-01594 - 03/05/2022
No-Filing date 20220400949 - 03/05/2022
No-Granting date 3110269 - 06/05/2022
No-EPO application date 16900546.9 - 27/04/2016
No-EPO granting date 3449939 - 30/03/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 5/2022 - 08/06/2022
Expiration date 28/04/2036
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities -
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 39/395
A61P 35/00
C07K 16/28

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1417275 GREEN CROSS CORPORATION 107 IHYEON-RO 30BEON-GIL GIHEUNG-GUYONGIN-SI, GYEONGGI-DO 16924 SOUTH KOREA
1417276 MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH 93, IHYEON-RO 30BEON-GIL GIHEUNG-GU YONGIN-SIGYEONGGI-DO 16924 SOUTH KOREA

Inventors
CodeFirstnameSurname
3654048 WON, JONG-HWA
3654049 LIM, YANGMI
3654050 HUR, MIN-KYU

Representatives
CodeFirstnameSurnameAddressTownZip
3463MARIAATHANASIADOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"KOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
848EFANGELIAGIAZITZOGLOU - THOMAIDOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
11/4/2024 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 10/2024 Αρ. Πρωτ. ΓΔ 3111/04.11.2024

Payments history 8 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).